INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

TXG10x Genomics, Inc.

CIK 0001770787

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 7
Max Insider Score31
Connections3with evidence

TXG · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
TA
Taich AdamChief Financial Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$77K
1,206 sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • ← Insider ofevidence
    Taich AdamChief Financial Officer · Sep 11, 2026
  • ← Insider ofevidence
    Saxonov SergeDirector, Chief Executive Officer · Aug 28, 2026
  • ← Holdsevidence
    ARK Investment Management LLC2.5% of reported portfolio · Aug 14, 2026
23
TA
Taich AdamChief Financial Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL
$2.02M
31.4K sh
Sep 9, 2026
Sep 11, 2026
traded Sep 9, 2026
+2d
SEC FORM 4

Evidence

16
TA
Taich AdamChief Financial Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$898K
13.8K sh
Sep 9, 2026Sep 11, 2026
traded Sep 9, 2026
+2dSEC FORM 4

Evidence

18
SS
Saxonov SergeDirector, Chief Executive Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$221K
3,500 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC FORM 4

Evidence

21
SS
Saxonov SergeDirector, Chief Executive Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$415K
6,494 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC FORM 4

Evidence

15
SS
Saxonov SergeDirector, Chief Executive Officer
TXG10x Genomics, Inc.
Open-market sale · 10b5-1 plan
SELL$32K
492 sh
Aug 26, 2026Aug 28, 2026
traded Aug 26, 2026
+2dSEC FORM 4

Evidence

31
ARK Investment Management LLC13F filer
TXG10x Genomics, Inc.
TRIM
SELL$65.72M
1.71M sh
Not disclosedAug 14, 2026quarterlySEC 13F

Evidence